Windtree Therapeutics Inc (WINT) poses a Brand-New Opportunity for Investors with beta value of 0.61
Windtree Therapeutics Inc (NASDAQ: WINT) open the trading on Thursday, with a bit cautious approach as it glided -5.23% to $0.10, before settling in for